Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
2
TLLTF Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
-35.47%
Day range:
$0.0002 - $0.0002
52-week range:
$0.0002 - $0.0340
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.84x
Volume:
12.5K
Avg. volume:
71K
1-year change:
-97.05%
Market cap:
$78.3K
Revenue:
$115.6M
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
$28.4M | -- | -23.11% | -- | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
NNVC
NanoViricides, Inc.
|
-- | -$0.20 | -- | -26.67% | $7.00 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.38 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
$0.0002 | -- | $78.3K | -- | $0.00 | 0% | 0.00x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$1.21 | $0.85 | $152.5M | 2.03x | $0.80 | 0% | 2.35x |
|
NNVC
NanoViricides, Inc.
|
$1.23 | $7.00 | $22.1M | -- | $0.00 | 0% | -- |
|
OGEN
Oragenics, Inc.
|
$0.88 | $2.00 | $727K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.23 | $7.00 | $7.6M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
284.7% | 0.814 | 4240% | 0.06x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
NNVC
NanoViricides, Inc.
|
-- | 0.464 | -- | 0.95x |
|
OGEN
Oragenics, Inc.
|
3.86% | -0.075 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -3.365 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TLLTF
TILT Holdings, Inc.
|
-$2.9M | -$5M | -79.4% | -501.61% | -47.75% | $2.2M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
NNVC
NanoViricides, Inc.
|
-$132.8K | -$1.8M | -92.29% | -92.29% | -- | -$1.7M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
TILT Holdings, Inc. vs. Competitors
-
Which has Higher Returns TLLTF or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of -255.85%. TILT Holdings, Inc.'s return on equity of -501.61% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About TLLTF or NBY?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -29.75%. Given that NovaBay Pharmaceuticals, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe NovaBay Pharmaceuticals, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is TLLTF or NBY More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock TLLTF or NBY?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or NBY?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. TILT Holdings, Inc.'s net income of -$9.2M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 2.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 2.35x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M NBYNovaBay Pharmaceuticals, Inc.2.35x 2.03x $521K -$1.3M
-
Which has Higher Returns TLLTF or NNVC?
NanoViricides, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat NanoViricides, Inc.'s return on equity of -92.29%.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M NNVCNanoViricides, Inc.-- -$0.10 $7.2M -
What do Analysts Say About TLLTF or NNVC?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NanoViricides, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 469.11%. Given that NanoViricides, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe NanoViricides, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 NNVCNanoViricides, Inc.0 0 0 -
Is TLLTF or NNVC More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison NanoViricides, Inc. has a beta of 1.158, suggesting its more volatile than the S&P 500 by 15.816%.
-
Which is a Better Dividend Stock TLLTF or NNVC?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoViricides, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. NanoViricides, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or NNVC?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than NanoViricides, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is lower than NanoViricides, Inc.'s net income of -$1.8M. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while NanoViricides, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus -- for NanoViricides, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M NNVCNanoViricides, Inc.-- -- -- -$1.8M
-
Which has Higher Returns TLLTF or OGEN?
Oragenics, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About TLLTF or OGEN?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 126.37%. Given that Oragenics, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe Oragenics, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 OGENOragenics, Inc.1 0 0 -
Is TLLTF or OGEN More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.781%.
-
Which is a Better Dividend Stock TLLTF or OGEN?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or OGEN?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Oragenics, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is lower than Oragenics, Inc.'s net income of -$3.1M. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns TLLTF or PTN?
Palatin Technologies has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M PTNPalatin Technologies-- -- -- -
What do Analysts Say About TLLTF or PTN?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than TILT Holdings, Inc., analysts believe Palatin Technologies is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 PTNPalatin Technologies0 0 0 -
Is TLLTF or PTN More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock TLLTF or PTN?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or PTN?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Palatin Technologies quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is higher than Palatin Technologies's net income of --. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns TLLTF or TOVX?
Theriva Biologics, Inc. has a net margin of -87.27% compared to TILT Holdings, Inc.'s net margin of --. TILT Holdings, Inc.'s return on equity of -501.61% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital TLLTFTILT Holdings, Inc.-27.64% -- $33.8M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About TLLTF or TOVX?
TILT Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3004.21%. Given that Theriva Biologics, Inc. has higher upside potential than TILT Holdings, Inc., analysts believe Theriva Biologics, Inc. is more attractive than TILT Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TLLTFTILT Holdings, Inc.0 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is TLLTF or TOVX More Risky?
TILT Holdings, Inc. has a beta of 0.126, which suggesting that the stock is 87.405% less volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.818%.
-
Which is a Better Dividend Stock TLLTF or TOVX?
TILT Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TILT Holdings, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TLLTF or TOVX?
TILT Holdings, Inc. quarterly revenues are $10.5M, which are larger than Theriva Biologics, Inc. quarterly revenues of --. TILT Holdings, Inc.'s net income of -$9.2M is lower than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, TILT Holdings, Inc.'s price-to-earnings ratio is -- while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TILT Holdings, Inc. is 0.00x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TLLTFTILT Holdings, Inc.0.00x -- $10.5M -$9.2M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
